Exploring the interaction between the antiallergic drug, tranilast and human serum albumin: Insights from calorimetric, spectroscopic and modeling studies

International Journal of Pharmaceutics

Volumn 491, Issue 1-2, 2015, Pages 352-358

  Tayyab, Saad ^a,b   Zaroog, Mohammed S ^a   Feroz, Shevin R ^a   Mohamad, Saharuddin B ^b   Malek, Sri Nurestri A ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Human serum albumin; Isothermal titration calorimetry; Ligand binding; Molecular docking; Tranilast

Indexed keywords

HUMAN SERUM ALBUMIN; TRANILAST; ANTHRANILIC ACID DERIVATIVE; ANTIALLERGIC AGENT; SERUM ALBUMIN;

ARTICLE; BINDING AFFINITY; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENERGY TRANSFER; ENTHALPY; ENTROPY; FLUORESCENCE SPECTROSCOPY; HYDROGEN BOND; HYDROPHOBICITY; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DOCKING; PRIORITY JOURNAL; STOICHIOMETRY; BINDING COMPETITION; BINDING SITE; CALORIMETRY; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; SPECTROFLUOROMETRY; THERMODYNAMICS; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-ALLERGIC AGENTS; BINDING SITES; BINDING, COMPETITIVE; CALORIMETRY; ENTROPY; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; ORTHO-AMINOBENZOATES; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; THERMODYNAMICS;

EID: 84937053473     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.06.042     Document Type: Article

References (33)

1. T. Amemiya, R. Koike, A. Kidera, and M. Ota PSCDB: a database for protein structural change upon ligand binding Nucleic Acids Res. 40 2012 D554 D558
2. H. Azuma, K. Banno, and T. Yoshimura Pharmacological properties of N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5), a new anti-atopic agent Br. J. Pharmacol. 58 1976 483 488
3. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The Protein Data Bank Nucleic Acids Res. 28 2000 235 242
4. R. Chakrabarti, V. Subramaniam, S. Abdalla, S. Jothy, and G.J. Prud'homme Tranilast inhibits the growth and metastasis of mammary carcinoma Anticancer Drugs 20 2009 334 345
5. E. Chambers, E.M. Hoey, A. Trudgett, I. Fairweather, and D.J. Timson Binding of serum albumin to the anthelmintic drugs albendazole, triclabendazole and their sulphoxides Vet. Parasitol. 171 2010 172 175
6. A. Cooper, C.M. Johnson, J.H. Lakey, and M. Nollmann Heat does not come in different colours: entropy-enthalpy compensation, free energy windows, quantum confinement, pressure perturbation calorimetry, solvation and the multiple causes of heat capacity effects in biomolecular interactions Biophys. Chem. 93 2001 215 230
7. F.A. De Wolf, and G.M. Brett Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands Pharmacol. Rev. 52 2000 207 236
8. S.R. Feroz, S.B. Mohamad, N. Bujang, S.N.A. Malek, and S. Tayyab Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin J. Agric. Food Chem. 60 2012 5899 5908
9. S.R. Feroz, S.B. Mohamad, Z.S.D. Bakri, S.N.A. Malek, and S. Tayyab Probing the interaction of a therapeutic flavonoid, pinostrobin with human serum albumin: multiple spectroscopic and molecular modeling investigations PloS ONE 8 2013 e76067
10. D.S. Goodsell, G.M. Morris, and A.J. Olson Automated docking of flexible ligands: Applications of AutoDock J. Mol. Recognit. 9 1999 1 5
11. J. Ghuman, P.A. Zunszain, I. Petitpas, A.A. Bhattacharya, M. Otagiri, and S. Curry Structural basis of the drug-binding specificity of human serum albumin J. Mol. Biol. 353 2005 38 52
12. X.M. He, and D.C. Carter Atomic structure and chemistry of human serum albumin Nature 358 1992 209 215
13. V.J. Hilser, J. Gomez, and E. Freire The enthalpy change in protein folding and binding: refinement of parameters for structure-based calculations Proteins 26 1996 123 133
14. M. Hiroi, M. Onda, E. Uchida, and T. Aimoto Anti-tumor effect of N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer J. Nippon Med. Sch. 69 2002 224 234
15. M. Isaji, H. Miyata, Y. Ajisawa, Y. Takehana, and N. Yoshimura Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo Br. J. Pharmacol. 122 1997 1061 1066
16. K. Izumi, A. Mizokami, Y.Q. Li, K. Narimoto, K. Sugimoto, Y. Kadono, Y. Kitagawa, H. Konaka, E. Koh, E.T. Keller, and M. Namiki Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes Prostate 69 2009 1222 1234
17. A. Koda, H. Nagai, S. Watanabe, Y. Yanagihara, and K. Sakamoto Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′) J. Allergy Clin. Immunol. 57 1976 396 407
18. U. Kragh-Hansen, V.T. Chuang, and M. Otagiri Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol. Pharm. Bull. 25 2002 695 704
19. J.R. Lakowicz Principles Of Fluorescence Spectroscopy 2006 Plenum Press New York
20. C.A. MacRaild, A.H. Daranas, A. Bronowska, and S.W. Homans Global changes in local protein dynamics reduce the entropic cost of carbohydrate binding in the arabinose-binding protein J. Mol. Biol. 368 2007 822 832
21. A. Pedretti, L. Villa, and G. Vistoli VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs J. Mol. Graphics Modell. 21 2002 47 49
22. T. Peters Jr. All About Albumin: Biochemistry, Genetics And Medical Applications 1996 Academic Press San Diego
23. C. Protogeraki, E.G. Andreadou, F. Perdih, I. Turel, A.A. Pantazaki, and G. Psomas Cobalt(II) complexes with the antimicrobial drug enrofloxacin: structure, antimicrobial activity, DNA- and albumin-binding Eur. J. Med. Chem. 86 2014 189 201
24. A. Ray Solvophobic interactions and micelle formation in structure forming nonaqueous solvents Nature 1971 313 315 230
25. P.D. Ross, and S. Subramanian Thermodynamics of protein association reactions: forces contributing to stability Biochemistry 20 1981 3096 3102
26. M.H. Sanner Python: a programming language for software integration and development J. Mol. Graphics Modell. 17 1999 57 61
27. P. Sevilla, J.M. Rivas, F. García-Blanco, J.V. García-Ramos, and S. Sánchez-Cortés Identification of the antitumoral drug emodin binding sites in bovine serum albumin by spectroscopic methods Biochim. Biophys. Acta 1774 2007 1359 1369
28. G. Sudlow, D. Birkett, and D. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 1976 1052 1061
29. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, and K. Kobayashi Crystal structure of human serum albumin at 2.5 Å resolution Protein Eng. 12 1999 439 446
30. 2 from human monocytes-macrophage Jpn. J. Pharmacol. 60 1992 85 90
31. H. Suzawa, S. Kikuchi, N. Arai, and A. Koda The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts Jpn. J. Pharmacol. 60 1992 91 96
32. H. Tamai, O. Katoh, S. Suzuki, K. Fujii, T. Aizawa, S. Takase, H. Kurogane, H. Nishikawa, T. Sone, K. Sakai, and T. Suzuki Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT) Am. Heart J. 138 1999 968 975
33. K. Wallevik Reversible denaturation of human serum albumin by pH, temperature and guanidine hydrochloride J. Biol. Chem. 245 1973 2650 2655